GENE ONLINE|News &
Opinion
Blog

2025-07-10|

Asymmetrical Onset of Parkinson’s Disease Linked to Motor and Non-Motor Symptom Progression

by Mark Chiang
Share To

Parkinson’s disease, a neurological disorder impacting an estimated 10 million individuals globally, often begins asymmetrically, affecting only one side of the body in its early stages. The condition is primarily characterized by motor symptoms such as tremors, slowed movement, and muscle rigidity. However, it also leads to non-motor complications including cognitive impairments, anxiety, and depression. Despite advancements in understanding the disease’s physical manifestations, the progression of these psychological and cognitive effects remains less clearly defined.

The asymmetrical onset of Parkinson’s disease raises questions about how the initially affected side may influence the overall course of the illness. Researchers continue to investigate this relationship to better understand its implications for both motor and non-motor symptoms. While motor issues are more visible and measurable, challenges like anxiety and depression add complexity to managing the disease. These findings highlight areas where further study is needed to improve treatment strategies for those living with Parkinson’s.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: July 7, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
Scroll to Top